Olgatech Pharmaceuticals Private Limited
About Olgatech Pharmaceuticals Private Limited
Data last updated:
Olgatech Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the repair services segment of the electronics sector. It was incorporated on 14 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52605WB2019PTC229795. Its GSTIN is 19AACCO8559K1ZQ (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hari Prasad Kabra and Raj Kumari Kabra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 11A Ballygunge Circular Road, Kolkata, West Bengal, India – 700019.
As per the financials filed for FY 2025, the company reported a revenue of ₹78,628, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹768 (net margin 1%) and EBITDA of ₹4,093 (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 124% over three years and 29% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Olgatech Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address11A Ballygunge Circular Road, Kolkata, West Bengal, India – 700019
- IndustryElectrnoics, Repair Services
To see the full contact details of Olgatech Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Olgatech Pharmaceuticals Private Limited
FY 2025 filings availableOlgatech Pharmaceuticals Private Limited reported revenue of ₹78,628 (up 192% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 192% growth in the latest year. EBITDA rose 131% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4,093 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹768 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Olgatech Pharmaceuticals Private Limited, buy the company report.
Board of directors of Olgatech Pharmaceuticals Private Limited
Olgatech Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Prasad Kabra Also directs: Sukriti Merchants Pvt Ltd | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
| Raj Kumari Kabra Also directs: Sukriti Merchants Pvt Ltd | Director | 14 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Olgatech Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zexo Pharmaceuticals Private Limited | ₹80,886 (FY 2019) | Noida, Uttar Pradesh, India | ||||
| S.V.Biovac Pharmaceuticals Pvt Ltd | ₹79,476 (FY 2025) | -98.0% | Bhopal, Madhya Pradesh, India | |||
| Joh Pharmaceuticals Private Limited | ₹79,433 (FY 2025) | Berhampore, West Bengal, India | ||||
| Mickle Felix Pharmaceuticals Private Limited | ₹79,195 (FY 2025) | -73.0% | Delhi, India | |||
| Shoundik Pharmaceuticals Private Limited | ₹78,708 (FY 2024) | Delhi, India | ||||
| Olgatech Pharmaceuticals Private Limitedthis company | ₹78,628 (FY 2025) | ₹768 | 1% | 192.0% | Kolkata, West Bengal, India | |
| Life Safety Pharmaceuticals Private Limited | ₹78,600 (FY 2024) | 176.0% | Delhi, India | |||
| Samax Pharmaceuticals Private Limited | ₹78,500 (FY 2019) | -34.0% | Lucknow, Uttar Pradesh, India | |||
| Parehab Pharmaceuticals Private Limited | ₹78,330 (FY 2025) | Delhi, India | ||||
| Niyash Pharmaceuticals Private Limited | ₹78,229 (FY 2025) | 182.0% | Khagaria, Bihar, India | |||
| Edge Cure Pharmaceuticals (OPC) Private Limited | ₹77,327 (FY 2022) | 253.0% | Amethi, Uttar Pradesh, India |
To see the full peer comparison of Olgatech Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Olgatech Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Olgatech Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Olgatech Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCO8559K1ZQ | West Bengal | Active | 14 Jan 2019 |
To see the full GST registrations and return filing status of Olgatech Pharmaceuticals Private Limited, buy the company report.
Recent activity
Olgatech Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Hari Prasad Kabra was appointed as Director on 14 Jan 2019.
Frequently asked questions
Olgatech Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in repair services, within the electronics industry. It was incorporated on 14 January 2019 (7+ years old) and is registered under CIN U52605WB2019PTC229795.
Olgatech Pharmaceuticals has 2 current directors:
- Hari Prasad Kabra - Director
- Raj Kumari Kabra - Director
The latest financial statements of Olgatech Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Olgatech Pharmaceuticals is 19AACCO8559K1ZQ, registered in West Bengal.
The CIN (Corporate Identification Number) of Olgatech Pharmaceuticals is U52605WB2019PTC229795. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Olgatech Pharmaceuticals was incorporated on 14 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Olgatech Pharmaceuticals by revenue are Zexo Pharmaceuticals Private Limited, S.V.Biovac Pharmaceuticals Pvt Ltd, Joh Pharmaceuticals Private Limited, Mickle Felix Pharmaceuticals Private Limited, Shoundik Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Hari Prasad Kabra was appointed as Director on 14 Jan 2019. Raj Kumari Kabra was appointed as Director on 14 Jan 2019.
The registered office of Olgatech Pharmaceuticals is at 11A Ballygunge Circular Road, Kolkata, West Bengal, India – 700019.
Olgatech Pharmaceuticals operates in the electronics industry, in the repair services segment.
The compliance status of Olgatech Pharmaceuticals is compliant as of 12 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
